ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

Survey supports removal of cancer care cuts from Medicare bills.

September 26, 2003

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975

Lynch Named Director, Yale Cancer Center

February 27, 2009

Fadlo Khuri Named Editor-in-Chief Of ACS Journal Cancer

August 12, 2011